PRECISIONheor

What PRECISIONheor does

PRECISIONheor is a New York-based health economics and outcomes research (HEOR) consulting firm founded in 2007, operating with 51-100 employees. Its core function is generating HEOR evidence and designing payer strategy and payer marketing programs that help pharmaceutical and biotech clients navigate payer complexity and optimize commercial success for new and existing therapies. The firm is part of the broader Precision Medicine Group, sitting alongside sister brand Precision AQ, which together offer an integrated agency-of-record platform spanning value and access, medical communications, investor relations, brand strategy, and data analytics. Within this ecosystem, PRECISIONheor provides the HEOR evidence-generation and access-strategy backbone, complemented by proprietary analytics products (AccessGenius, OncoGenius, Data Solutions, EHR Solutions, Omnichannel Solutions) that operationalize market potential evaluation and targeting across therapeutic areas including Oncology, Rare Disease, Immunology, Neurology, and Cardio Renal Metabolic.

Revenue mechanics are professional services-based: engagements are quote-based and project or retainer driven, sold through enterprise sales targeting commercial leaders at top pharmaceutical and biotech companies. The go-to-market is enterprise and field-led, with teams embedded within client commercialization organizations as an extension of internal functions rather than transactional vendor relationships. Select evidence of scale includes support for FDA drug launches in 2024 and an international footprint covering the US and UK. Pricing is not publicly disclosed, and no funding rounds, public listings, or revenue figures were identified in the source data, indicating a privately held, profitable-services operating posture under the Precision Medicine Group parent.

Name

PRECISIONheor

Legal name

Precision AQ

Website

https://precisionheor.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

PRECISIONheor is a New York-based health economics and outcomes research consulting firm that generates HEOR evidence and payer strategy for pharmaceutical and biotech companies. It operates within Precision Medicine Group alongside Precision AQ, serving enterprise clients across multiple therapeutic areas including oncology and rare disease.

Ownership category

akta.pro rank

Product category

HEOR Consulting

NAICS

Professional, Scientific, and Technical Services (541), Scientific Research and Development Services (5417), Marketing Consulting Services (541613)

akta.pro primary industry

Health Economics & Outcomes Research (HEOR) (HLAIAKAB)

akta.pro secondary industries

Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

Keywords

• Health economics research
• Outcomes research consulting
• HEOR consulting services
• Market access strategy
• Payer evidence generation

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Professional Services - Agency of Record: Precision AQ operates as an agency of record providing integrated services across market access, HEOR, medical communications, investor relations, and brand strategy. Revenue is generated through consulting engagements, retainer agreements, and project-based professional services for pharmaceutical and biotech commercialization needs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PRECISIONheor is a health economics and outcomes research (HEOR) consulting firm that generates economic, clinical, and real-world evidence to support market access, payer strategy, and reimbursement decisions for pharmaceutical and biotech therapies. The firm operates within the Precision AQ commercialization platform, combining HEOR expertise with broader value-and-access, data analytics, and payer-marketing capabilities to help drug developers navigate payer complexity and optimize commercial success.

Product overview

Precision AQ is a multi-solution platform providing integrated services and technology products for pharmaceutical and biotech commercialization. The product portfolio includes five core offerings: AccessGenius (market access data solution), Data Solutions (patient/payer/provider analytics), EHR Solutions (electronic health record integration), Omnichannel Solutions (multi-channel engagement), and OncoGenius (oncology-specific analytics). These products are complemented by service divisions covering Value & Access (including HEOR, Access Consulting, Market Access Agency), Medical Communications (Peer-to-Peer Marketing, Medical Affairs, Learning & Development), Investor Relations & External Communications, Brand Strategy & Marketing, and Data Insights & Analytics. The platform spans four therapeutic areas: Immunology, Neurology, Oncology, and Rare Disease, with Cardio Renal Metabolic as an additional focus area.

Differentiator

Problem solved

Functional benefit

Brands

• AccessGenius: Product offering for market access solutions
• OncoGenius
• Data Solutions
• EHR Solutions
• Omnichannel Solutions

Products and services

• HEOR Consulting A consulting service that develops HEOR evidence (economic modeling, real-world data research, outcomes analysis) to help pharmaceutical and biotech clients demonstrate product value to payers and support market access.
• Value & Access Services An integrated service offering that combines HEOR evidence generation, payer strategy, and market access support to help drug developers navigate payer complexity and optimize commercial success.
• Access Consulting A consulting service that develops payer strategy and payer marketing plans to support market access and reimbursement for pharmaceutical and biotech therapies.

Quantifiable outcome

• Supported a percentage of all FDA-approved drugs launched in 2024

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Evidera: Evidera is a dedicated HEOR, market access, and real-world evidence consulting firm (now part of PPD/Thermo Fisher), serving the same pharma and biotech customers with overlapping value, access, and evidence-generation services — directly comparable to PRECISIONheor's core offering.
• Xcenda: Xcenda is a market access, HEOR, and reimbursement consulting firm (part of Cencora/AmerisourceBergen) that provides payer strategy, health economics, and real-world evidence services to pharma manufacturers — a direct peer in the same HEOR advisory space.
• Charles River Associates (CRA Health Economics & Market Access): CRA's Life Sciences practice delivers HEOR, market access, pricing, and evidence-based consulting to pharma and biotech clients — directly comparable to PRECISIONheor's payer strategy and health economics work.
• Analysis Group: Analysis Group is a consulting firm with a large health economics and outcomes research practice serving pharma, biotech, and medical device clients — closely matching PRECISIONheor's HEOR consulting model and customer base.
• Trinity Life Sciences: Trinity Life Sciences provides commercial strategy, market access, HEOR, and real-world evidence consulting to pharma and biotech — overlapping directly with Precision AQ's payer strategy, value & access, and evidence generation offerings.

Broad incumbents

• IQVIA: IQVIA is the largest healthcare data, analytics, and consulting platform, offering HEOR, real-world evidence, and market access services alongside clinical research and commercial solutions — a broad incumbent that overlaps heavily with Precision AQ's payer strategy and evidence-generation work.
• Syneos Health: Syneos Health is a large biopharmaceutical solutions organization combining clinical development with commercialization and market access consulting — directly competing for the same pharma AOR and commercialization engagements as Precision AQ.
• Parexel International: Parexel is a global CRO with dedicated market access, HEOR, and commercialization consulting capabilities, serving the same pharma/biotech client base and competing for integrated commercialization engagements.
• ZS Associates: ZS Associates is a global consulting firm with deep pharma commercial and market access practices, advising the same top-pharma commercial leaders that Precision AQ targets as AOR clients.
• Decision Resources Group (Clarivate): Decision Resources Group (now part of Clarivate) provides market access insights, epidemiology, and HEOR data and advisory services to pharma — adjacent peer delivering evidence and payer analytics that compete for similar budget allocations.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precisionheor
• Xx.com/precisionheor

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PRECISIONheor